Juan M. Melero-Martin, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endothelial Cells | 27 | 2024 | 3586 | 3.380 |
Why?
|
Tissue Engineering | 17 | 2023 | 1890 | 2.200 |
Why?
|
Neovascularization, Physiologic | 17 | 2024 | 1369 | 2.110 |
Why?
|
Microvessels | 5 | 2021 | 586 | 1.650 |
Why?
|
Pericytes | 3 | 2024 | 299 | 1.350 |
Why?
|
Fetal Blood | 9 | 2020 | 1353 | 1.340 |
Why?
|
Stem Cells | 14 | 2023 | 3538 | 1.300 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2024 | 1890 | 1.200 |
Why?
|
Mesenchymal Stem Cells | 11 | 2024 | 1671 | 1.180 |
Why?
|
Hydrogels | 7 | 2023 | 745 | 1.130 |
Why?
|
Blood Vessels | 5 | 2021 | 1112 | 1.070 |
Why?
|
Bioengineering | 2 | 2019 | 100 | 1.040 |
Why?
|
Cell Differentiation | 14 | 2024 | 11674 | 0.950 |
Why?
|
Mice, Nude | 17 | 2024 | 3635 | 0.920 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2024 | 703 | 0.820 |
Why?
|
Pluripotent Stem Cells | 4 | 2024 | 808 | 0.800 |
Why?
|
Doxycycline | 1 | 2024 | 348 | 0.800 |
Why?
|
Islets of Langerhans Transplantation | 6 | 2024 | 748 | 0.740 |
Why?
|
Mesenchymal Stem Cell Transplantation | 6 | 2015 | 507 | 0.730 |
Why?
|
Transcription Factors | 6 | 2024 | 12174 | 0.720 |
Why?
|
Biological Assay | 2 | 2021 | 629 | 0.710 |
Why?
|
Neuregulin-1 | 1 | 2021 | 136 | 0.690 |
Why?
|
Blood Cells | 2 | 2014 | 308 | 0.650 |
Why?
|
Factor VIII | 1 | 2019 | 349 | 0.570 |
Why?
|
Paracrine Communication | 2 | 2021 | 278 | 0.570 |
Why?
|
Molecular Biology | 1 | 2021 | 573 | 0.570 |
Why?
|
Ischemia | 2 | 2024 | 1900 | 0.570 |
Why?
|
Colony-Forming Units Assay | 2 | 2014 | 352 | 0.560 |
Why?
|
Hemophilia A | 1 | 2019 | 359 | 0.530 |
Why?
|
Endothelium, Vascular | 5 | 2015 | 4425 | 0.500 |
Why?
|
Neovascularization, Pathologic | 9 | 2018 | 2643 | 0.490 |
Why?
|
Cells, Cultured | 17 | 2023 | 19041 | 0.490 |
Why?
|
Myocytes, Cardiac | 3 | 2021 | 1683 | 0.490 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2430 | 0.490 |
Why?
|
Gelatin | 2 | 2015 | 230 | 0.480 |
Why?
|
Mice | 38 | 2024 | 82045 | 0.480 |
Why?
|
Osteogenesis | 2 | 2021 | 1296 | 0.470 |
Why?
|
Cell Culture Techniques | 5 | 2023 | 1669 | 0.450 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 183 | 0.440 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 2014 | 595 | 0.430 |
Why?
|
Adult Stem Cells | 2 | 2013 | 222 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2014 | 254 | 0.430 |
Why?
|
Methacrylates | 1 | 2013 | 110 | 0.420 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2022 | 1121 | 0.400 |
Why?
|
Chondrogenesis | 2 | 2021 | 239 | 0.400 |
Why?
|
Chondrocytes | 2 | 2009 | 799 | 0.400 |
Why?
|
Animals | 47 | 2024 | 169418 | 0.400 |
Why?
|
Bioartificial Organs | 2 | 2015 | 47 | 0.380 |
Why?
|
Insulin-Secreting Cells | 3 | 2024 | 900 | 0.360 |
Why?
|
Tissue Scaffolds | 6 | 2021 | 948 | 0.360 |
Why?
|
Mitochondria | 1 | 2024 | 3672 | 0.360 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 371 | 0.340 |
Why?
|
Collagen | 5 | 2023 | 2646 | 0.330 |
Why?
|
Blood Vessel Prosthesis | 2 | 2011 | 959 | 0.320 |
Why?
|
Microfluidics | 1 | 2014 | 675 | 0.320 |
Why?
|
Tissue Culture Techniques | 1 | 2009 | 290 | 0.290 |
Why?
|
Erythropoiesis | 1 | 2011 | 694 | 0.290 |
Why?
|
Erythropoietin | 1 | 2011 | 719 | 0.280 |
Why?
|
Cell Separation | 5 | 2019 | 1726 | 0.270 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2008 | 305 | 0.250 |
Why?
|
Genetic Engineering | 1 | 2011 | 936 | 0.250 |
Why?
|
Extracellular Matrix | 5 | 2024 | 1738 | 0.250 |
Why?
|
Cryopreservation | 1 | 2010 | 731 | 0.250 |
Why?
|
Laminin | 3 | 2021 | 407 | 0.240 |
Why?
|
Myocardial Infarction | 4 | 2023 | 11515 | 0.240 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11930 | 0.230 |
Why?
|
Pre-Eclampsia | 1 | 2014 | 1257 | 0.230 |
Why?
|
Cell Count | 3 | 2019 | 1835 | 0.230 |
Why?
|
Fibrin | 2 | 2021 | 515 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2017 | 3520 | 0.220 |
Why?
|
Pericardium | 3 | 2014 | 679 | 0.220 |
Why?
|
Nerve Tissue | 1 | 2023 | 78 | 0.220 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 3440 | 0.220 |
Why?
|
Humans | 52 | 2024 | 768451 | 0.210 |
Why?
|
Proteoglycans | 2 | 2021 | 807 | 0.200 |
Why?
|
Anemia | 1 | 2011 | 1521 | 0.190 |
Why?
|
Cartilage, Articular | 2 | 2006 | 1104 | 0.190 |
Why?
|
Cell Proliferation | 8 | 2019 | 10494 | 0.190 |
Why?
|
Endocardial Fibroelastosis | 1 | 2021 | 66 | 0.190 |
Why?
|
Hematopoietic Stem Cells | 2 | 2013 | 3408 | 0.180 |
Why?
|
Nanopores | 1 | 2021 | 48 | 0.180 |
Why?
|
Nanofibers | 1 | 2021 | 68 | 0.180 |
Why?
|
Receptors, Interleukin-8A | 1 | 2020 | 47 | 0.180 |
Why?
|
Polyurethanes | 1 | 2021 | 110 | 0.180 |
Why?
|
Receptors, Interleukin-8B | 1 | 2020 | 58 | 0.180 |
Why?
|
Immunomodulation | 2 | 2022 | 550 | 0.180 |
Why?
|
Endocardium | 1 | 2021 | 249 | 0.180 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2415 | 0.180 |
Why?
|
Biomimetics | 1 | 2021 | 172 | 0.170 |
Why?
|
Mice, SCID | 3 | 2021 | 2633 | 0.170 |
Why?
|
Drug Combinations | 2 | 2021 | 2079 | 0.160 |
Why?
|
Histiocytosis | 1 | 2019 | 39 | 0.160 |
Why?
|
Biocompatible Materials | 3 | 2021 | 1703 | 0.160 |
Why?
|
Blood Coagulation Tests | 1 | 2019 | 271 | 0.160 |
Why?
|
Phenotype | 6 | 2022 | 16712 | 0.150 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2017 | 65 | 0.140 |
Why?
|
Transforming Growth Factor beta | 3 | 2021 | 2003 | 0.140 |
Why?
|
Protein Kinases | 1 | 2024 | 1608 | 0.140 |
Why?
|
Muscles | 2 | 2023 | 1582 | 0.140 |
Why?
|
Oligodendroglia | 1 | 2020 | 538 | 0.140 |
Why?
|
Body Mass Index | 1 | 2013 | 13030 | 0.130 |
Why?
|
Myocardium | 2 | 2023 | 4788 | 0.120 |
Why?
|
Coculture Techniques | 2 | 2020 | 1343 | 0.120 |
Why?
|
Islets of Langerhans | 1 | 2021 | 1349 | 0.120 |
Why?
|
History, 21st Century | 1 | 2021 | 1575 | 0.120 |
Why?
|
Tyrphostins | 1 | 2014 | 63 | 0.120 |
Why?
|
Gene Transfer Techniques | 1 | 2019 | 1209 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1905 | 0.120 |
Why?
|
Flow Cytometry | 4 | 2014 | 5904 | 0.120 |
Why?
|
Pulmonary Valve | 2 | 2010 | 413 | 0.120 |
Why?
|
Models, Statistical | 1 | 2009 | 5103 | 0.110 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2015 | 344 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2019 | 1162 | 0.110 |
Why?
|
Adipose Tissue | 2 | 2018 | 3335 | 0.110 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1502 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5887 | 0.110 |
Why?
|
History, 20th Century | 1 | 2021 | 2772 | 0.110 |
Why?
|
Energy Metabolism | 1 | 2024 | 2901 | 0.100 |
Why?
|
Cattle | 3 | 2011 | 3830 | 0.100 |
Why?
|
Embryonic Stem Cells | 1 | 2019 | 1249 | 0.100 |
Why?
|
Dogs | 3 | 2021 | 3847 | 0.100 |
Why?
|
Hemangioma | 2 | 2008 | 727 | 0.100 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2022 | 26 | 0.100 |
Why?
|
Antigens, Surface | 2 | 2014 | 1615 | 0.100 |
Why?
|
Thymosin | 1 | 2011 | 47 | 0.100 |
Why?
|
Transplantation, Heterologous | 2 | 2011 | 2393 | 0.100 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2012 | 426 | 0.090 |
Why?
|
Rheology | 2 | 2011 | 349 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1602 | 0.090 |
Why?
|
Subcutaneous Tissue | 1 | 2011 | 132 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20231 | 0.090 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18388 | 0.090 |
Why?
|
Kinetics | 2 | 2009 | 6348 | 0.090 |
Why?
|
Myeloid Cells | 2 | 2017 | 833 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1468 | 0.090 |
Why?
|
Neoplasms | 3 | 2018 | 22386 | 0.080 |
Why?
|
Nanoparticles | 1 | 2021 | 1986 | 0.080 |
Why?
|
Neoplastic Stem Cells | 2 | 2008 | 1357 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2013 | 1494 | 0.080 |
Why?
|
Transfection | 3 | 2011 | 5767 | 0.080 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1674 | 0.080 |
Why?
|
Organ Specificity | 1 | 2013 | 1972 | 0.080 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 794 | 0.070 |
Why?
|
Male | 15 | 2024 | 364781 | 0.070 |
Why?
|
Graft Rejection | 1 | 2021 | 4505 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2019 | 2102 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2020 | 12813 | 0.070 |
Why?
|
Collagen Type I | 1 | 2011 | 620 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7605 | 0.070 |
Why?
|
Neoplasms, Experimental | 1 | 2012 | 1232 | 0.070 |
Why?
|
Multipotent Stem Cells | 1 | 2008 | 200 | 0.070 |
Why?
|
Pregnancy | 3 | 2014 | 30179 | 0.070 |
Why?
|
Umbilical Veins | 1 | 2007 | 425 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2126 | 0.070 |
Why?
|
Canada | 1 | 2022 | 2143 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22365 | 0.060 |
Why?
|
Endostatins | 1 | 2006 | 168 | 0.060 |
Why?
|
Cell Movement | 2 | 2017 | 5223 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2022 | 6241 | 0.060 |
Why?
|
Immunocompromised Host | 1 | 2011 | 867 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2011 | 809 | 0.060 |
Why?
|
Cell Division | 1 | 2013 | 4479 | 0.060 |
Why?
|
Porosity | 1 | 2006 | 352 | 0.060 |
Why?
|
Horseradish Peroxidase | 2 | 2015 | 170 | 0.060 |
Why?
|
Bone Marrow | 2 | 2019 | 2929 | 0.060 |
Why?
|
Heart Valves | 1 | 2006 | 284 | 0.060 |
Why?
|
Regenerative Medicine | 1 | 2008 | 311 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5709 | 0.060 |
Why?
|
Radiation Injuries | 1 | 2011 | 1205 | 0.060 |
Why?
|
Perfusion | 1 | 2009 | 1402 | 0.060 |
Why?
|
Saphenous Vein | 1 | 2007 | 519 | 0.060 |
Why?
|
Culture Media | 1 | 2006 | 899 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2010 | 825 | 0.050 |
Why?
|
Kidney | 1 | 2019 | 7064 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2011 | 5308 | 0.050 |
Why?
|
Mesoderm | 1 | 2006 | 679 | 0.050 |
Why?
|
Cell Survival | 1 | 2013 | 5801 | 0.050 |
Why?
|
Surface Properties | 1 | 2006 | 1168 | 0.050 |
Why?
|
Cell Lineage | 1 | 2012 | 2575 | 0.050 |
Why?
|
Equipment Failure Analysis | 2 | 2015 | 848 | 0.050 |
Why?
|
Cross-Linking Reagents | 2 | 2015 | 692 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3611 | 0.050 |
Why?
|
Polyglycolic Acid | 2 | 2015 | 408 | 0.050 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2021 | 110 | 0.050 |
Why?
|
Green Fluorescent Proteins | 3 | 2014 | 2072 | 0.050 |
Why?
|
Polyesters | 2 | 2015 | 375 | 0.050 |
Why?
|
Premature Birth | 1 | 2013 | 1816 | 0.050 |
Why?
|
Biology | 1 | 2023 | 291 | 0.050 |
Why?
|
Cell Communication | 1 | 2008 | 1662 | 0.050 |
Why?
|
Adult | 5 | 2023 | 223542 | 0.050 |
Why?
|
Terminology as Topic | 2 | 2019 | 1539 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 2017 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11138 | 0.040 |
Why?
|
Injections | 2 | 2015 | 840 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 397 | 0.040 |
Why?
|
Losartan | 1 | 2021 | 263 | 0.040 |
Why?
|
Australia | 1 | 2023 | 1264 | 0.040 |
Why?
|
Peptides | 1 | 2011 | 4368 | 0.040 |
Why?
|
Rats | 3 | 2021 | 23839 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8635 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2011 | 3939 | 0.040 |
Why?
|
Erythrocytes | 1 | 2007 | 2422 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2021 | 909 | 0.040 |
Why?
|
Female | 8 | 2017 | 396943 | 0.040 |
Why?
|
Macrophages | 1 | 2012 | 5797 | 0.030 |
Why?
|
Systems Biology | 1 | 2020 | 481 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 3437 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 757 | 0.030 |
Why?
|
Melanoma | 1 | 2014 | 5740 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2020 | 1094 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2013 | 26395 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2017 | 7599 | 0.030 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 161 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30243 | 0.030 |
Why?
|
Hindlimb | 1 | 2017 | 516 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65409 | 0.030 |
Why?
|
Adipocytes | 2 | 2014 | 1199 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1053 | 0.030 |
Why?
|
Doxorubicin | 1 | 2021 | 2229 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 2014 | 79 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2076 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1840 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2014 | 184 | 0.030 |
Why?
|
Vascular Grafting | 1 | 2015 | 163 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2017 | 547 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2014 | 473 | 0.030 |
Why?
|
Phosphoproteins | 2 | 2014 | 2450 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2298 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2010 | 6400 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10865 | 0.020 |
Why?
|
Up-Regulation | 2 | 2014 | 4138 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 548 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1395 | 0.020 |
Why?
|
Materials Testing | 1 | 2015 | 871 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 561 | 0.020 |
Why?
|
Swine | 1 | 2021 | 5996 | 0.020 |
Why?
|
Phenols | 1 | 2015 | 520 | 0.020 |
Why?
|
Cadherins | 1 | 2015 | 906 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2062 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2012 | 522 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1195 | 0.020 |
Why?
|
Tamoxifen | 1 | 2014 | 968 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2238 | 0.020 |
Why?
|
Heart | 2 | 2014 | 4451 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1969 | 0.020 |
Why?
|
Prospective Studies | 1 | 2014 | 54914 | 0.020 |
Why?
|
Heart Injuries | 1 | 2011 | 207 | 0.020 |
Why?
|
Carrier Proteins | 2 | 2014 | 4948 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2015 | 2126 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2008 | 186 | 0.020 |
Why?
|
Retroviridae | 1 | 2010 | 850 | 0.020 |
Why?
|
Antigens, Nuclear | 1 | 2008 | 184 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2477 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2014 | 17149 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11206 | 0.020 |
Why?
|
Sheep | 1 | 2010 | 1451 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 74915 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3530 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6606 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7449 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2008 | 475 | 0.020 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2006 | 71 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5803 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6527 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3463 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 595 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2969 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4029 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9376 | 0.020 |
Why?
|
Lactic Acid | 1 | 2010 | 1140 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2008 | 665 | 0.010 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9507 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2010 | 2696 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1660 | 0.010 |
Why?
|
United States | 1 | 2022 | 73121 | 0.010 |
Why?
|
Polymers | 1 | 2010 | 1631 | 0.010 |
Why?
|
Liver | 1 | 2019 | 7575 | 0.010 |
Why?
|
Clone Cells | 1 | 2006 | 1672 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6091 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5808 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15460 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13452 | 0.010 |
Why?
|
DNA | 1 | 2015 | 7213 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9558 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4984 | 0.010 |
Why?
|
Prostate | 1 | 2010 | 1781 | 0.010 |
Why?
|
Skin | 1 | 2015 | 4520 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17647 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2006 | 1869 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3442 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4180 | 0.010 |
Why?
|
Homeostasis | 1 | 2011 | 3351 | 0.010 |
Why?
|
Fetus | 1 | 2006 | 1883 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23638 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9263 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5891 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9505 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40271 | 0.000 |
Why?
|
Infant | 1 | 2008 | 36497 | 0.000 |
Why?
|
Aged | 1 | 2019 | 171520 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36840 | 0.000 |
Why?
|
Middle Aged | 1 | 2006 | 223418 | 0.000 |
Why?
|